Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.23.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Revenues
General and administrative costs:        
Compensation to related parties, including stock-based compensation expense of $280,060 and $424,094 for the three months ended June 30, 2023 and 2022, respectively, and $557,040 and $763,766 for the six months ended June 30, 2023 and 2022, respectively 522,561 753,530 1,042,041 1,319,452
Patent and licensing legal and filing fees and costs 340,010 358,389 657,350 673,626
Other costs and expenses 379,970 269,281 724,212 584,023
Research and development costs 427,457 164,810 616,542 623,261
Total costs and expenses 1,669,998 1,546,010 3,040,145 3,200,362
Loss from operations (1,669,998) (1,546,010) (3,040,145) (3,200,362)
Interest income 2,714 191 7,729 300
Interest expense (1,948) (627) (5,809) (3,121)
Foreign currency gain (loss) 877 142 2,211 (39)
Net loss $ (1,668,355) $ (1,546,304) $ (3,036,014) $ (3,203,222)
Net loss per common share - basic $ (1.00) $ (0.95) $ (1.82) $ (2.14)
Net loss per common share - diluted $ (1.00) $ (0.95) $ (1.82) $ (2.14)
Weighted average common shares outstanding - basic 1,665,956 1,620,091 1,665,479 1,498,076
Weighted average common shares outstanding - diluted 1,665,956 1,620,091 1,665,479 1,498,076